Abstract
Purpose:to present an overview of domestic and foreign current research covering the treatment of late-life depression.Materials and method:the keywords “depressive disorder”, “late age”, “psychopharmacotherapy” were used to search for scientific articles in the databases MedLine, PubMed for the period 2000–2020.Discussion and conclusions:the variability of multiple aging factors in depressive patients of late age leads to significant heterogeneity of geriatric depressions and difficulties in selection of therapy. In the current literature on the treatment of late-life depression, there are quite heterogeneous recommendations on the choice of different drugs, recommended dosages, duration of therapy and time to replace drugs if they are ineffective. The global trend of transition to personalized therapy of mental diseases requires identification of predictors of therapeutic response in patients. Significant data has already been accumulated on potential predictors of therapeutic response to antidepressants in young and middle-aged patients using clinical, neurobiological, neurocognitive and genetic parameters. The search for predictors of therapeutic response is especially important in late life, since the selection of adequate antidepressant therapy is associated not only with the effectiveness, but also with the safety of treatment of elderly patients. To date our knowledge of the problem of predicting the therapeutic response in this group of patients remains very limited and requires further study
Highlights
Summary Purpose: to present an overview of domestic and foreign current research covering the treatment of late-life depression
Discussion and conclusions: the variability of multiple aging factors in depressive patients of late age leads to significant heterogeneity of geriatric depressions and difficulties in selection of therapy
Significant data has already been accumulated on potential predictors of therapeutic response to antidepressants in young and middle-aged patients using clinical, neurobiological, neurocognitive and genetic parameters
Summary
Резюме Цель: представить обзор отечественных и зарубежных современных исследований, освещающих вопросы терапии депрессий позднего возраста. Обсуждение и выводы: вариабельность многочисленных факторов старения у депрессивных больных позднего возраста приводит к значительной гетерогенности гериатрических депрессий и трудностям подбора терапии. Поиск предикторов терапевтического ответа особенно важен в позднем возрасте, поскольку подбор адекватной антидепрессивной терапии связан не только с эффективностью, но и безопасностью лечения пожилых пациентов. The search for predictors of therapeutic response is especially important in late life, since the selection of adequate antidepressant therapy is associated with the effectiveness, and with the safety of treatment of elderly patients. Подбор терапии геронтопсихиатрическим больным терапевтического ответа, тенденцией к развитию несопровождается особыми трудностями также и в связи полных последующих ремиссий и повышенным риском с высокой отягощенностью данной возрастной группы развития деменции [22,23,24,25]. Для лечения аффективных расстройств в позднем расстройствами, что оказывает влияние на переноси- возрасте преимущественно используется психофармость и безопасность терапии
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
